causaLens
PrivateLast Round
Series A
Jan 27, 2022
Est. Valuation
$250M
Total Funding Raised
$51.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
causaLens is an artificial intelligence company that provides a causal AI platform designed to help enterprises automate decision-making and optimize business outcomes.
Sector
AI, Data & Cloud Infrastructure
Verticals
ML Platforms, Business Intelligence, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
causaLens Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
causaLens Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 27, 2022 | ||||
| Seed | Apr 1, 2019 | ||||
| Seed | Nov 27, 2018 |
Key People
Founding team and executive leadership
causaLens Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Generation Ventures | Series A, Seed |
| Dorilton Ventures | Series A |
| LetterOne | Series A |
| Dorilton | Series A |
| IQ Capital | Seed, Series A |
| Dorilton Ventures | Series A |
| Generation Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
IPG Group referenced as a new customer.
- Mar 1, 2026
Johnson & Johnson, Syneos Health, and Cisco referenced as clients.
causaLens Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about causaLens's valuation, stock price, and market status.